HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

WholePeople.com Launch Aims To Revive Struggling Amrion Business

This article was originally published in The Tan Sheet

Executive Summary

Whole Foods Market remains "optimistic" that the recent sluggish performance of its former Amrion subsidiary can be reversed with new marketing support under the WholePeople.com e-commerce venture.

You may also be interested in...



Whole Foods' Amrion Business Future Weighed

Amrion may be on the selling block due to a soft supplements market and unfavorable investment results. The supplement manufacturer and direct marketer's parent company, Whole Foods Market, retained the investment banking firm Dain Raushcer Wessels to help it consider "strategic alternatives."

WholePeople.com, Amrion Web Business Merged With Gaiam.com

A new plan to restructure Amrion will bring profitability to the struggling dietary supplement direct marketer "by the end of fiscal year 2001," parent company Whole Foods Market predicted.

WholePeople.com

Whole Foods Market announces Jan. 14 the formation of WholePeople.com, an e-commerce company offering products such as nutritional supplements, herbals and alternative/holistic health care items. WholePeople has issued $35 mil. in common stock to the venture capital firms Oak Investment Partners, Invesco Private Capital, North Castle Partners and Essex Woodlands Health Ventures in exchange for a 22% minority interest in the company. Whole Foods, which owns the supplement firm Amrion, initially created WholePeople as a subsidiary

Related Content

Topics

UsernamePublicRestriction

Register

RS133516

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel